drugset / Trial / NCT01009216
A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospinal Fluid
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objectives of this study are to assess the cerebral spinal fluid (CSF) pharmacokinetics and the plasma/CSF pharmacokinetic/pharmacodynamic relationship of ABT-384 in healthy male volunteers.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-384 | Small molecule | — | — |
Indications
No indication recorded.